Lankoff, A.; Czerwińska, M.; Walczak, R.; Karczmarczyk, U.; Tomczyk, K.; Brzóska, K.; Fracasso, G.; Garnuszek, P.; Mikołajczak, R.; Kruszewski, M.
Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and Biodistribution. Int. J. Mol. Sci. 2021, 22, 5702.
https://doi.org/10.3390/ijms22115702
AMA Style
Lankoff A, Czerwińska M, Walczak R, Karczmarczyk U, Tomczyk K, Brzóska K, Fracasso G, Garnuszek P, Mikołajczak R, Kruszewski M.
Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and Biodistribution. International Journal of Molecular Sciences. 2021; 22(11):5702.
https://doi.org/10.3390/ijms22115702
Chicago/Turabian Style
Lankoff, Anna, Malwina Czerwińska, Rafał Walczak, Urszula Karczmarczyk, Kamil Tomczyk, Kamil Brzóska, Giulio Fracasso, Piotr Garnuszek, Renata Mikołajczak, and Marcin Kruszewski.
2021. "Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and Biodistribution" International Journal of Molecular Sciences 22, no. 11: 5702.
https://doi.org/10.3390/ijms22115702
APA Style
Lankoff, A., Czerwińska, M., Walczak, R., Karczmarczyk, U., Tomczyk, K., Brzóska, K., Fracasso, G., Garnuszek, P., Mikołajczak, R., & Kruszewski, M.
(2021). Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and Biodistribution. International Journal of Molecular Sciences, 22(11), 5702.
https://doi.org/10.3390/ijms22115702
